BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23290780)

  • 1. Therapeutic potential of targeting SK1 in human cancers.
    Alshaker H; Sauer L; Monteil D; Ottaviani S; Srivats S; Böhler T; Pchejetski D
    Adv Cancer Res; 2013; 117():143-200. PubMed ID: 23290780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.
    Pchejetski D; Böhler T; Stebbing J; Waxman J
    Nat Rev Urol; 2011 Sep; 8(10):569-678. PubMed ID: 21912422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 as an anticancer therapeutic target.
    Gao Y; Gao F; Chen K; Tian ML; Zhao DL
    Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase 1 in cancer.
    Heffernan-Stroud LA; Obeid LM
    Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
    Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
    Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
    Ader I; Malavaud B; Cuvillier O
    Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha.
    Pettus BJ; Bielawski J; Porcelli AM; Reames DL; Johnson KR; Morrow J; Chalfant CE; Obeid LM; Hannun YA
    FASEB J; 2003 Aug; 17(11):1411-21. PubMed ID: 12890694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on the role of sphingosine 1-phosphate in cancer.
    Pyne S; Pyne NJ
    Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
    Huwiler A; Zangemeister-Wittke U
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel sphingosine kinase 1 inhibitors.
    Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.
    Gault CR; Obeid LM
    Crit Rev Biochem Mol Biol; 2011 Aug; 46(4):342-51. PubMed ID: 21787121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
    Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
    Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
    Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
    Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular signalling by sphingosine kinase and sphingosine 1-phosphate.
    Leclercq TM; Pitson SM
    IUBMB Life; 2006 Aug; 58(8):467-72. PubMed ID: 16916784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
    Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
    Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase 1 is up-regulated in colon carcinogenesis.
    Kawamori T; Osta W; Johnson KR; Pettus BJ; Bielawski J; Tanaka T; Wargovich MJ; Reddy BS; Hannun YA; Obeid LM; Zhou D
    FASEB J; 2006 Feb; 20(2):386-8. PubMed ID: 16319132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of regulation of sphingosine kinase 1.
    Pulkoski-Gross MJ; Obeid LM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1413-1422. PubMed ID: 30591148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.